Literature DB >> 9292947

Identification of a new thyroglobulin variant: a guanine-to-adenine transition resulting in the substitution of arginine 2510 by glutamine.

F M Mendive1, L C Rossetti, G Vassart, H M Targovnik.   

Abstract

We analyzed thyroglobulin (Tg) reverse transcription polymerase chain reaction (RT-PCR) products from three congenital goiters and three normal thyroid tissues by Taq I digestion. Tg coding sequences were amplified from position 57 to 8448 in 12 amplification fragments. A Taq I restriction fragment length polymorphism was detected in the most 3' RT-PCR product (nt 7584 through 8448). Data from the sequence showed a G-->A transition (nt 7627) causing the disappearance of the Taq I site in position 7625. It produced the substitution of arginine for a glutamine at position 2510. Afterwards, we established that the glutamine allele is present in normal unrelated individuals, with an allelic frequency of 62%. This Tg variant is thus widely represented in the human population. The available sequence information from rat and bovine Tg showed the presence, in both, of glutamine at position 2510.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292947     DOI: 10.1089/thy.1997.7.587

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  2 in total

1.  Association of the TGrI29 microsatellite in thyroglobulin gene with autoimmune thyroiditis in a Argentinian population: a case-control study.

Authors:  Viviana Varela; Leonardo Rizzo; Sabina Domené; Oscar D Bruno; Mariana L Tellechea; Carina M Rivolta; Héctor M Targovnik
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

2.  Analysis of thyroglobulin gene polymorphisms in patients with autoimmune thyroiditis.

Authors:  Mariela Caputo; Carina M Rivolta; Teresa Mories; Juan J Corrales; Purificación Galindo; Rogelio González-Sarmiento; Héctor M Targovnik; José M Miralles-García
Journal:  Endocrine       Date:  2010-03-18       Impact factor: 3.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.